After two strong years driven by the global pandemic, the German life sciences industry did not perform as well in terms of equity investment in 2022. As Biotechgate data shows, venture investment in biotech companies fell by almost half as compared to 2021, and with only USD 419 million in equity funding, is at its … Continue reading Germany Life Science Trend Analysis 2023
Category: Germany
Yearly Life Sciences Reports of Germany
Germany Life Science Market Trend Analysis 2022
While not reaching the levels of 2020 – the year COVID-19 became a top priority for life science sectors – the life science industry in Germany is still performing strongly. In 2021, it was second-highest in terms of private equity investment value since we started tracking the data. Germany has a strong focus on research … Continue reading Germany Life Science Market Trend Analysis 2022
Germany Life Science Market Trend Analysis 2021
Even though most industries have been badly affected by the global pandemic, German life sciences thrived in 2020. The total value of private equity investments doubled compared to 2019 and was the highest since we started tracking the data. There are at least 840 human therapeutics in different stages of development which makes Germany one … Continue reading Germany Life Science Market Trend Analysis 2021
German Life Science Market Trend Analysis 2020
This month we are presenting the annual life science market trend report for Germany that was created thanks to the cooperation with our partners: BIO Deutschland, HEALTH MADE IN GERMANY, Cluster Biotechnology North Rhine-Westphalia, and BioRN. With about 1,200 active companies, over 500 assets available for licensing and 478 million dollars of venture capital attracted … Continue reading German Life Science Market Trend Analysis 2020
German Life Sciences Market Trend Analysis 2019
We are proud to present the annual trend report for the German life sciences market. The report was compiled using data gathered from Biotechgate Business Development Database, in cooperation with our partners: HEALTH MADE IN GERMANY, BIO Deutschland, Cluster Biotechnology North Rhine-Westphalia, and BioValley Germany. Download the report Would you like to be notified about … Continue reading German Life Sciences Market Trend Analysis 2019
German Biotech Market Trend Analysis 2018
This month we are presenting a trend analysis of the German life sciences industry. The country remains one of the largest life sciences markets in the world with well over 3,000 companies listed in Biotechgate, out of which more than 1,000 are biotech entities. German biotech is well invested and the first half of 2018 … Continue reading German Biotech Market Trend Analysis 2018
German Life Sciences Trend Analysis 2017
Compared to previous years, few new biotech companies were founded in Germany in 2016. However, the German life sciences industry remains strong and stable, due to a large number of already existing companies and the substantial financing rounds that have taken place. Please click on the link below for the full report. German LS Trend … Continue reading German Life Sciences Trend Analysis 2017
German Life Sciences Trend Analysis 2016
2015 was a quiet year in terms of the emergence of new private German biotech companies but in terms of financing, the 12 months remained steady. That being said it was not enough to match the high of the latter half of 2014, where USD 247.5m was raised. Read the full report below. German LS … Continue reading German Life Sciences Trend Analysis 2016
German Life Sciences Trend Analysis 2015
Venture financing of German biotechnology companies drop to normal levels in 2015 following the best year for venture financing in the last 5 years. In the first half of 2015, close to USD 90m was raised in 5 financing rounds. German LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use … Continue reading German Life Sciences Trend Analysis 2015
German Life Sciences Trend Analysis 2014
In 2013, the total financing value raised by private, Biotech companies in Germany was reduced by 31% compared to last year’s figure (USD 210m from what was USD 305m in 2012). However, this summer’s snapshot of the German biotech industry, suggests that the therapeutics pipeline is revitalized, since the number of products in earlier stages … Continue reading German Life Sciences Trend Analysis 2014